Bayer Pharmaceuticals COO: The 2024 campaign is full of good intentions — and bad policy

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. You can also read Sandoz CEO Richard Saynor on what the 2024 conversation is missing.

The future of health care starts on Jan. 20, 2025. The stakes for Americans could not be higher.

Whether it’s Vice President Kamala Harris or former President Donald Trump in the White House that day, the health care industry must not lose sight of what matters most: giving all Americans more affordable access to the most innovative medicines.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

MSU researchers develop method for earlier disease detection using blood proteins

Medical professionals have long known that the earlier a disease is detected, the higher the chance for a better patient outcome.

November 19, 2024

Bamboo Health Launches Discharge Summaries to Streamline Follow Up Care

What You Should Know: – Bamboo Health has announced a new solution called Discharge Summaries, which is an enhancement to its existing Pings platform. –

November 13, 2023

Xlife Sciences AG Completes Strategic Review Process by Q3 2024 – Biotech Investments

Xlife Sciences AG / Key word(s): Miscellaneous 03-Sep-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is

September 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.